您现在位置： -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Anti-parkinson drugs market report

讯：

Market report of anti-parkinson drugs (2007 edition)

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  March 2007
Format:  Adobe PDF
Price:  US$ 2,200
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68052505
E-mail: bianch@healthoo.com   wuhf@healthoo.com

Table of contents
1 Summary
2 Classfication of anti-parkinson drugs and overview of market
  2.1 Epidemic trend of anti-parkinson drugs and case rate
  2.2 Classfication of anti-parkinson drugs
  2.3 General situation about the development of anti-parkinson drugs
3 Market statistic of anti-parkinson drugs
  3.1 Total market scales of antipsychotic drugs from 2002 to 2006
  3.2 Market shares of different antipsychotic drugs from 2002 to 2006
  3.3 Analysis on key breeds
     3.3.1 Benserazide
     3.3.2 Pergolide
     3.3.3 Levodopa/Carbidopa
4. Market shares of different brands
   4.1 Regional distribution of brands
   4.2 Market shares of different brands in key cities
      4.2.1 Beijing
      4.2.2 Shanghai
      4.2.3 Guangzhou
      4.2.4 Others
5 R&D information
  5.1 List of domestic marketed products and import procucts
  6.2 List of enterprises which are applying the registertion of Sulpiride

Tables and figures
Table 1 Classfication of anti-parkinson drugs
Table 2 Sales rank of antipsychotic drugs from 2002 to 2006
Table 3 Market scales of Benserazide from 2002 to 2006
Table 4 Market scales of Pergolide from 2002 to 2006
Table 5 Market shares of different brands in Beijing in 2005
Table 6 Market shares of different brands in Beijing in 2006
Table 7 Market shares of different brands in Shanghai in 2005
Table 8 Market shares of different brands in Shanghai in 2006
Table 9 Market shares of different brands in Guangzhou in 2005
Table 10 Market shares of different brands in Guangzhou in 2006
Table 11 Market shares of different brands in other cities in 2005
Table 12 Market shares of different brands in other cities in 2006
Table 13 List of anti-parkinson drugs produced by domestic enterprises
Table 14 List of imported anti-parkinson drugs
Table 15 List of enterprises which are applying the registertion of anti-parkinson drugs

Figure 1 Growth trend of anti-parkinson drugs from 2002 to 2006
Figure 2 Growth trend of anti-parkinson drugs with different admi from 2002 to 2006
Figure 3 Sales comparison of top 5 anti-parkinson drugs from 2002 to 2006
Figure 4 Growth trend of Benserazide from 2002 to 2006
Figure 5 Market shares of different enterprises producing Benserazide from 2002 to 2006
Figure 6 Growth trend of Pergolide from 2002 to 2006
Figure 7 Market shares of different enterprises producing Pergolide from 2002 to 2006
Figure 8 Growth trend of Levodopa/Carbidopa from 2002 to 2006
Figure 9 Market shares of different brands from 2002 to 2006
Figure 10 Market shares of different brands in key cities in 2005
Figure 11 Market shares of different brands in key cities in 2006
Figure 12 Market shares of different brands in Beijing, Shanghai, Guangzhou in 2005
Figure 13 Market shares of different brands in Beijing, Shanghai, Guangzhou in 2006